These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 28640706)

  • 1. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers and therapeutic advances in glioblastoma multiforme.
    Sasmita AO; Wong YP; Ling APK
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma.
    Sugimoto K; Ideguchi M; Kimura T; Kajiwara K; Imoto H; Sadahiro H; Ishii A; Kawano H; Ikeda E; Suzuki M
    Brain Tumor Pathol; 2016 Apr; 33(2):137-46. PubMed ID: 26667174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma biomarkers from bench to bedside: advances and challenges.
    Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
    Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
    Mrugala MM
    Discov Med; 2013 Apr; 15(83):221-30. PubMed ID: 23636139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of multifocal and multicentric glioblastoma.
    Li Y; Zhang ZX; Huang GH; Xiang Y; Yang L; Pei YC; Yang W; Lv SQ
    J Clin Neurosci; 2021 Jan; 83():71-76. PubMed ID: 33358091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
    Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
    Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
    Chinot OL; de La Motte Rouge T; Moore N; Zeaiter A; Das A; Phillips H; Modrusan Z; Cloughesy T
    Adv Ther; 2011 Apr; 28(4):334-40. PubMed ID: 21432029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent and ongoing clinical trials in glioblastoma.
    Lombardi G
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):480-483. PubMed ID: 30067618
    [No Abstract]   [Full Text] [Related]  

  • 10. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
    Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
    Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
    Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
    J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
    Kim HJ; Kim DY
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
    Jarzabek MA; Sweeney KJ; Evans RL; Jacobs AH; Stupp R; O'Brien D; Berger MS; Prehn JH; Byrne AT
    Drug Discov Today; 2013 Nov; 18(21-22):1052-66. PubMed ID: 23792334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme: a review of therapeutic targets.
    Kanu OO; Mehta A; Di C; Lin N; Bortoff K; Bigner DD; Yan H; Adamson DC
    Expert Opin Ther Targets; 2009 Jun; 13(6):701-18. PubMed ID: 19409033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic markers for glioblastoma.
    Jung CS; Unterberg AW; Hartmann C
    Histol Histopathol; 2011 Oct; 26(10):1327-41. PubMed ID: 21870336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging: diagnosis and response assessment in glioblastoma.
    Clarke JL; Chang SM
    Cancer J; 2012; 18(1):26-31. PubMed ID: 22290254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor infiltrating CD63 positive cells on survival in patients with glioblastoma multiforme.
    Kase M; Adamson A; Saretok M; Minajeva A; Vardja M; Jõgi T; Asser T; Jaal J
    J Neurosurg Sci; 2016 Dec; 60(4):417-23. PubMed ID: 25215582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.